Ser Educacional (SEER3) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
19 May, 2026Executive summary
Net income rose 66.4% year-over-year in 2Q25 to R$81.3 million, the highest since 1Q16, with net margin up 4.6 p.p. to 13.8%.
Adjusted EBITDA increased 25.0% to R$163.2 million, with margin up 3.2 p.p. to 27.7%.
Double-digit growth in enrollments, especially in hybrid and medical programs, drove expansion in EBITDA and net margins.
Operational cash generation post-CapEx surged 729.8% year-over-year, nearly matching last year's total.
Debt reduced by over BRL 100 million year-over-year, with net debt/adjusted EBITDA at 1.24x, the lowest in recent years.
Financial highlights
Net revenue grew 10.7% year-over-year in Q2 to R$470.0 million, with Q1 revenue up 20% due to the CES/Ser Solidário program.
Adjusted net income reached R$86.5 million, up 87.3% from 2Q24.
Gross margin improved 4.6 p.p. to 60.3%, and adjusted EBITDA margin reached 27.7%.
Pre-CapEx operating cash flow grew 42.8% year-over-year; post-CapEx cash flow surged 729.8%.
Average ticket increased, with hybrid education up 2.9% and digital education facing pricing pressure but maintaining ticket.
Outlook and guidance
Management expects continued value generation through operational efficiency, organic growth, and expansion in health and law courses.
Operational model to be replicated in new markets with established brand recognition.
Expansion of medical course offerings and participation in public calls for new medical vacancies.
Conservative approach to ProUni offerings, with expectations for continued organic growth and efficiency improvements.
Latest events from Ser Educacional
- Net income surged 74% with strong on-campus growth, higher margins, and reduced net debt.SEER3
Q1 202619 May 2026 - Revenue and EBITDA surged in 3Q24, driven by health course growth and margin expansion.SEER3
Q3 202419 May 2026 - Adjusted net income rose 8.5% to R$46.2M, with margin and cash flow gains from hybrid and health courses.SEER3
Q2 202419 May 2026 - Record EBITDA and net income driven by hybrid and medical growth, efficiency, and deleveraging.SEER3
Q1 202519 May 2026 - Strong 4Q24: EBITDA up 18%, net income up 101%, debt down 9.3%, and dividends resumed.SEER3
Q4 202419 May 2026 - Adjusted net income surged 112% and net debt fell 30%, led by hybrid and medical school growth.SEER3
Q4 202515 May 2026 - Adjusted net income up 24.5% and net debt down 21.9% on Hybrid Learning and margin gains.SEER3
Q3 202517 Nov 2025